FIORF logo

Fiore Cannabis Ltd. (FIORF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

FIORF, $ (piyasa değeri 0) fiyatla Healthcare işi olan Fiore Cannabis Ltd.'i temsil ediyor. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 55/100 puan alıyor.

Son analiz: 17 Mar 2026
55/100 AI Puanı

Fiore Cannabis Ltd. (FIORF) Sağlık ve Boru Hattı Genel Bakışı

CEOErik Anderson
MerkezKelowna, CA
Halka Arz Yılı2015
SektörHealthcare

Fiore Cannabis Ltd. operates in the U.S. cannabis market, focusing on cultivation, production, and distribution of medical and recreational marijuana. The company also runs a dispensary in California, integrating both upstream and downstream operations within a competitive and evolving regulatory landscape.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 17 Mar 2026

Yatırım Tezi

Fiore Cannabis Ltd. presents a speculative investment opportunity within the evolving U.S. cannabis market. The company's vertical integration, encompassing cultivation, production, and retail through its California dispensary, offers potential for margin capture across the value chain. However, the company's negative profit margin of -280.9% indicates significant operational challenges. Key catalysts include potential regulatory changes in the U.S. that could expand market access. Investors should closely monitor the company's ability to improve profitability and manage its operations effectively. The company's beta of 0.83 suggests lower volatility compared to the overall market. The absence of a dividend reflects its focus on reinvesting earnings for growth. The market capitalization of $0.00B indicates that it is a micro-cap stock.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Operates in the U.S. medical and recreational cannabis market.
  • Vertically integrated with cultivation, production, and retail operations.
  • Gross margin of 22.6% indicates potential for profitability improvements.
  • Negative profit margin of -280.9% reflects current operational challenges.
  • Beta of 0.83 suggests lower volatility compared to the market.

Rakipler & Benzerleri

Güçlü Yönler

  • Vertically integrated operations.
  • Dispensary in California.
  • Focus on both medical and recreational markets.

Zayıflıklar

  • Negative profit margin.
  • Limited geographic presence.
  • Small market capitalization.

Katalizörler

  • Upcoming: Potential changes in U.S. federal cannabis regulations could expand market access and reduce regulatory burdens.
  • Ongoing: Expansion of operations into new states as cannabis legalization progresses.
  • Ongoing: Development and launch of new cannabis-infused products to meet evolving consumer demand.
  • Ongoing: Strategic partnerships and acquisitions to enhance capabilities and market reach.

Riskler

  • Ongoing: Intense competition in the cannabis industry could pressure margins and limit market share.
  • Potential: Fluctuations in cannabis prices could impact revenue and profitability.
  • Potential: Changes in state and local regulations could create compliance challenges and increase costs.
  • Potential: Limited access to capital could constrain growth opportunities.
  • Ongoing: Negative profit margin indicates operational inefficiencies.

Büyüme Fırsatları

  • Expansion into New Markets: Fiore Cannabis can explore opportunities to expand its operations into additional states as cannabis legalization progresses across the U.S. This includes states with established medical cannabis programs and those considering recreational legalization. Entering new markets would require navigating different regulatory frameworks and establishing local partnerships. The U.S. cannabis market is projected to reach $40 billion by 2030, offering significant growth potential for companies that can successfully expand their geographic footprint. Timeline: Ongoing.
  • Product Innovation and Development: Fiore Cannabis can invest in research and development to create new and innovative cannabis products, such as edibles, concentrates, and topicals. This includes developing products with specific cannabinoid profiles and formulations to target different consumer needs and preferences. The market for cannabis-infused products is growing rapidly, driven by increasing consumer interest in alternative consumption methods. By developing differentiated products, Fiore Cannabis can enhance its brand reputation and attract new customers. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: Fiore Cannabis can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This includes partnering with other cannabis companies, technology providers, and distribution networks. Acquisitions can provide access to new markets, technologies, and product lines. Strategic partnerships can help Fiore Cannabis leverage the expertise and resources of other companies to accelerate its growth. Timeline: Ongoing.
  • Optimization of Cultivation and Production Processes: Fiore Cannabis can focus on optimizing its cultivation and production processes to improve efficiency and reduce costs. This includes implementing advanced cultivation techniques, such as hydroponics and vertical farming, to maximize yields and minimize resource consumption. By improving its operational efficiency, Fiore Cannabis can enhance its profitability and competitiveness. Timeline: Ongoing.
  • Enhancement of Retail Operations: Fiore Cannabis can enhance its retail operations by improving the customer experience and expanding its product offerings. This includes creating a welcoming and informative retail environment, providing personalized customer service, and offering a wide range of cannabis products and accessories. By enhancing its retail operations, Fiore Cannabis can attract and retain customers, increase sales, and build brand loyalty. Timeline: Ongoing.

Fırsatlar

  • Expansion into new states.
  • Development of new cannabis products.
  • Strategic partnerships and acquisitions.

Tehditler

  • Changing regulations.
  • Intense competition.
  • Fluctuations in cannabis prices.

Rekabet Avantajları

  • Vertical integration provides control over the supply chain.
  • Dispensary operations provide direct access to consumers.
  • Brand recognition in the California market.

FIORF Hakkında

Fiore Cannabis Ltd., formerly known as Citation Growth Corp., rebranded in October 2020 to reflect its focus on the cannabis industry. Incorporated in 2007 and headquartered in Kelowna, Canada, the company cultivates, produces, and distributes medical and recreational marijuana in the United States. Fiore Cannabis operates a dispensary in California, allowing it to directly serve consumers. The company's operations span the entire value chain, from cultivation to retail, positioning it as a vertically integrated player in the cannabis market. Fiore Cannabis aims to capitalize on the growing demand for cannabis products in the U.S., navigating the complex regulatory environment to establish a strong market presence. The company's strategy involves optimizing its cultivation and production processes to ensure high-quality products and efficient operations. By focusing on both medical and recreational markets, Fiore Cannabis seeks to diversify its revenue streams and cater to a broad customer base.

Ne Yaparlar

  • Cultivates medical marijuana.
  • Cultivates recreational marijuana.
  • Produces medical marijuana products.
  • Produces recreational marijuana products.
  • Distributes medical marijuana products.
  • Distributes recreational marijuana products.
  • Operates a dispensary in California.

İş Modeli

  • Cultivation and production of cannabis.
  • Distribution of cannabis products to dispensaries.
  • Retail sales through its own dispensary.

Sektör Bağlamı

Fiore Cannabis Ltd. operates within the rapidly expanding U.S. cannabis industry. The market is characterized by increasing legalization, evolving regulations, and growing consumer demand for both medical and recreational cannabis products. The industry is highly competitive, with numerous players vying for market share. Key trends include the consolidation of smaller companies, the development of new cannabis-infused products, and the increasing focus on quality and branding. Fiore Cannabis competes with other cannabis producers and retailers, including CBGI, HCANF, LOWLF, MDIT, and MDXL, all of whom are navigating similar regulatory and market dynamics.

Kilit Müşteriler

  • Medical marijuana patients in the U.S.
  • Recreational cannabis users in the U.S.
  • Dispensaries in California.
AI Güveni: 69% Güncellendi: 17 Mar 2026

Finansallar

Grafik & Bilgi

Fiore Cannabis Ltd. (FIORF) hisse senedi fiyatı: Price data unavailable

Son Haberler

FIORF için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

FIORF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

FIORF için Wall Street fiyat hedefi analizi.

MoonshotScore

55/100

Bu puan ne anlama geliyor?

MoonshotScore, FIORF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Erik Anderson

CEO

Erik Anderson serves as the CEO of Fiore Cannabis Ltd. His background includes experience in the cannabis industry, with a focus on operations and business development. He has been involved in various aspects of the cannabis value chain, from cultivation to retail. Anderson's expertise lies in navigating the complex regulatory landscape and building sustainable business models in the cannabis sector. He is committed to driving growth and innovation at Fiore Cannabis.

Sicil: Under Erik Anderson's leadership, Fiore Cannabis Ltd. has focused on expanding its operations in the U.S. cannabis market. Key milestones include the rebranding of the company and the optimization of its cultivation and production processes. Anderson has also overseen the development of new cannabis products and the enhancement of the company's retail operations. His strategic decisions have aimed at improving the company's profitability and competitiveness.

FIORF OTC Piyasa Bilgileri

The OTC Other tier, also known as the Pink Sheets, represents the lowest tier of the over-the-counter (OTC) market. Companies listed on this tier typically do not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. This tier is often populated by speculative or distressed companies, and may include companies with limited operating history or those that are thinly traded. Investing in companies on the OTC Other tier carries significant risks due to the lack of regulatory oversight and transparency.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity for FIORF on the OTC market is likely to be limited. As an OTC Other stock, it may experience low trading volume and wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. This lack of liquidity can increase the risk of price volatility and make it challenging to exit a position quickly. Investors should be aware of these liquidity constraints when considering an investment in FIORF.
OTC Risk Faktörleri:
  • Limited financial disclosure.
  • Low trading volume and liquidity.
  • Potential for price manipulation.
  • Lack of regulatory oversight.
  • Speculative nature of the business.
Durum Tespiti Kontrol Listesi:
  • Verify the company's legal standing and registration.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive position.
  • Evaluate the management team's experience and track record.
  • Understand the regulatory environment and potential risks.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor.
Meşruiyet Sinyalleri:
  • Operation of a dispensary in California.
  • Focus on both medical and recreational markets.
  • Rebranding efforts to focus on the cannabis industry.

FIORF Healthcare Hisse Senedi SSS

FIORF için değerlendirilmesi gereken temel faktörler nelerdir?

Fiore Cannabis Ltd. (FIORF) şu anda yapay zeka skoru 55/100, orta puanı gösteriyor. Temel güçlü yan: Vertically integrated operations.. İzlenmesi gereken birincil risk: Ongoing: Intense competition in the cannabis industry could pressure margins and limit market share.. Bu bir finansal tavsiye değildir.

FIORF MoonshotScore'u nedir?

FIORF şu anda MoonshotScore'da 55/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

FIORF verileri ne sıklıkla güncellenir?

FIORF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler FIORF hakkında ne diyor?

FIORF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

FIORF'a yatırım yapmanın riskleri nelerdir?

FIORF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition in the cannabis industry could pressure margins and limit market share.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

FIORF'ın P/E oranı nedir?

FIORF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için FIORF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

FIORF aşırı değerli mi, yoksa düşük değerli mi?

Fiore Cannabis Ltd. (FIORF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

FIORF'ın temettü verimi nedir?

Fiore Cannabis Ltd. (FIORF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is limited due to the company's OTC listing.
  • Analyst coverage is unavailable.
  • The cannabis industry is subject to rapid regulatory changes.
Veri Kaynakları

Popüler Hisseler